SlideShare uma empresa Scribd logo
1 de 27
Drug Testing in the
Workplace
Judith Soto – Group Leader, Mitchell
Bragg, Reyes Gutierrez, & Brandon
Edwards
PSY 103
Summer 2013
Introduction
Substance abuse has made it necessary for many American
firms to create strategies that would help keep it out of the
workplace. Employment drug testing is a powerful risk tool
that provides far-reaching organizational benefits. Some firms
have sponsored extravagant programs to control alcohol and
drug abuse. However, these programs have tended to rely on a
supervisor's, a coworker's, or an employee's judgment about
the presence of substance abuse in another individual or
themselves. In the 1980s, some firms began to adopt drug and
alcohol testing as an fair strategy to detect and control
substance abuse. Supporters of this approach claim that an
employee's positive test results can be linked to impairments
in job performance, safety risks, and absenteeism. The drug
testing industry was born 30 years ago, after the launch of
federal drug testing requirements in the 1980s.
What is the Definition of drugs?
• Any substance that when taken into the living
organism may modify one or more of its functions.
• This definition includes aspirin, milk of magnesia,
penicillin, caffeine, alcohol, marijuana, and cocaine.
Drug Testing Trends
• There has been a
growing trend of drug
testing from the mid-
1980’s to the present.
• One study shows that
18% of Fortune 500
companies tested
employees in 1985, and
1991 the proportion
double to more than
40%.
Drug Testing Trends Cont.
• A survey in 1988
indicated increases in
the testing of both
applicants and current
employees for drugs.
• 38% of organizations
tested job applicants, to
28% in 1987.
• 36% tested current
employees, to 28%
1986.
Drug Testing Trends Cont.
• By 1991, 48% of
Fortune 1000 firms
engaged in some type
of drug testing.
• Recent studies have
shown about 42% get
pre-employment
tested.
• About 29% already
employed get tested.
Drug Testing Pros
• Pre-employment testing
can identify users and
prevent cost of
recruitment and
training.
• Random-testing can
help raise awareness
and deter illegal drug
use.
Drug Testing Pros Cont.
• Testing can prevent
accidents
• It can reduce
compensation cost
• Prevent abusers from
taking away from the
company’s competitive
edge.
• Testing programs have
been shown to improve
employee morale and
productivity
Drug Testing Pros Cont.
• Testing can reduce
absenteeism.
• Reduce turnover and
theft rates.
• Vacant positions, as
they become available,
will attract mature,
responsible, drug-free
applicants.
Drug Testing Pros Cont.
• Drug addicts will soon be
eliminated from the
workplace.
• Improved efficiency and
heightened public
confidence in the product
and/or services of the
company may cover and
even exceed the cost of
testing.
Drug Testing Cons Cont.
• Management won't win any
workplace popularity contests.
• Management may be accused of
invading employees' privacy. A
written agreement of compliance
with the drug-testing policy must be
signed by each employee prior to its
implementation. Signing the same
agreement will be a condition of
employment for future recruits to the
organization.
Drug Testing Cons Cont.
• Management may wish to
offer a signing bonus to
help retain reliable, long-
term employees.
• Testing equipment and
personnel may be
expensive. However, bulk
rates are often available for
large companies.
Drug Testing Cons Cont.
• Although drug testing detects
recent drug use, it does not show
if an employee is presently
impaired and unable to perform
job functions.
• Drug users work only two thirds
as efficiently ad nonusers
• Companies pay up to 300 percent
more for medical cost for drug
users that for nonusers.
Drug Testing Cons Cont.
• The cost of worker’s
compensation claims tend
to be about five times
higher for users than
nonusers.
Facts:
• In 1997, two states – Arizona
and California – adopted laws
that permit the use of
marijuana for certain specific
medical purposes.
• Americans concerned about the
“drug problem” has two parts:
o One involves the misuse of legal
and potentially helpful drugs such
as codeine and morphine.
o Two involves illegal drugs with no
medical value such as LSD and
heroin.
More Facts:
• Research indicates that 74
percent of illicit drug
users are employed in
full-time positions.
• One out of four hospital
admissions is from drug
use.
• Forty percent of all
accidents that result in
hospitalization are
because of drugs.
More Facts:
• The national cost of all accidents
from drug abuse is $41 billion per
year.
• The Drug-Free Act of 1988
requires Federal grantees and
contractors having a contract for
property or services of $25,000
or more to provide a drug free
workplace.
More Facts:
• While marijuana is still the number one most-abused drug
globally, prescription drugs have moved into second place,
overshadowing cocaine. Technology has played a big role in these
changes. For example, the street distributor has morphed into the
Internet distributor, making it easier than ever to access
prescription medication without ever visiting a doctor.
• The use of pill mills, which are clinics, doctors, or pharmacies that
are prescribing large amounts of prescription medication for non-
medical use, is also becoming prominent in the United States,
prompting abusers to travel across state lines to access these mills
• Drug Identification Kits: Law enforcement and school officials now
have the ability to instantly test substances found while out in the
field or on school premises. It is a very cost-effective method of
substance testing, and eliminates the need for lab analysis which
can cost up to $200-300.
What Can Be Tested?
• Metabolites and Metabolism
• Urine
• Drug Urinalysis
• Breath
• Saliva
• Blood
• Hair
• Sweat
Testing Methods Confirmatory Tests
• Immunoassays
• Enzyme Immunoassays
• Radioimmunoassay
• Gas Chromatography
• Mass Spectrometry
• Thin-Layer
Chromatography
What to Avoid Before A Drug Test
• Alka-Seltzer Plus
• Allerest
• Bronkaid
• Contac
• Donnagel
• Nyquil
• Primatene
• Sinutab
• Sudafed
• Triaminic
• Poppy seeds
Drug Detection Periods For Urine
Initial Test
Confirmation Test
Drug Testing by Industry
Conclusion
• There are many pros and cons to drug testing but there is
one thing that no one can dispute and that is the fact that
drugs do impair a person as long as the drugs are in their
system.
• Consequences of drug use are NOT restricted to a minority
of heavy users or “addicts” who are easily identified.
• Often problems can arise from occasional use/intoxication.
• Most workplaces are concerned about the impact alcohol
and other drugs may have in their workplace.
• Most workplaces have at least one response in place to
address alcohol and other drug related harm.
• Most workplaces are not considering doing anything further
to address alcohol and other drug issues.
Works Consulted
• Beverly A. Potter, Ph.D. and J. Sebastian Orfali, M.A. Pass The Test An Employee Guide To
Drug Testing. Berkeley: Ronin Publishing, Inc, 1999.
• Breugem, Lindsay. SafeWork. 2006. 26 June 2013
<http://www.safework.sa.gov.au/uploaded_files/workplace_report.pdf>.
• Colakis, Peter N., and Roger Bruce. "Drug Testing In The Workplace." Professional Safety
52.7 (2007): 31-36. Academic Search Premier. Web. 24 June 2013.
• DiThomas, Melissa. Occupational Health & Safety. 1 October 2012. 26 June 2013
<http://ohsonline.com/Articles/2012/10/01/Drug-Testing-Promotes-Workplace-
Safety.aspx?m=1>.
• Employment Background Solutions. 2010. 26 June 2013 <http://www.ebiinc.com/drug-
testing-facts.html>.
• Get The Facts. 1998-2013. 26 June 2013
<http://www.drugwarfacts.org/cms/Drug_Testing_Employee#sthash.uhZ4VfQE.Q2vPSI93.d
pbs.
• Hartwell, Tyler D.Steele, Paul D. "Prevalence Of Drug Testing In The Workplace." Monthly
Labor Review 119.11 (1996): 35. MasterFILE Premier. Web. 24 June 2013.
Works Consulted Cont.• Gray, James. Tikkun. 25 June 2013. 26 June 2013 <http://www.tikkun.org/nextgen/drug-
prohibition-is-the-problem-reflections-from-a-former-judge>.
• Monroe, Judy. The Facts About Drug Testing. New York: Macmillan Publishing Company,
1990.
• Newton, David E. Drug Testing An Issue for School, Sports, and Work. Berkely Heights:
Enslow Publishers, 1999.
• Office of Justice Programs. n.d. 26 June 2013 <http://www.bjs.gov/content/dcf/du.cfm >.
• Steeves, Richard. "Recognising Drug Abuse At Work." Occupational Health 63.9 (2011): 27-
30. Academic Search Premier. Web. 24 June 2013.
• West, Robert H. Coombs and Louis Jolyon. Drug Testing Issues & Options. New York: Oxford
Universtity Press, 19991.
• Wikipedia The Free Encyclopedia. 26 June 2013. 26 June 2013
<https://en.wikipedia.org/wiki/Psychoactive_drug>.
• Zeidner, Rita. "PUTTING DRUG SCREENING TO THE TEST. (Cover Story)." HR Magazine 55.11
(2010): 25. MasterFILE Premier. Web. 24 June 2013.
• 2013. 26 June 2013 <http://www.testcountry.com/categories.html?cat=256&left>.

Mais conteúdo relacionado

Mais procurados

Exploratory drug research
Exploratory drug researchExploratory drug research
Exploratory drug researchNitisha Thakur
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practicessuraj p rajan
 
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...Use of Chemical Characterization to Assess the Equivalency of Medical Devices...
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...NAMSA
 
Good Laboratory Practices.pptx
Good Laboratory Practices.pptxGood Laboratory Practices.pptx
Good Laboratory Practices.pptxVUJJINIKHILKUMAR
 
Analysis of raw materials
Analysis of raw materialsAnalysis of raw materials
Analysis of raw materialsSkAzizuddin1
 
SAE REPORTING TIMELINE AND COMPENSATION 2019
SAE REPORTING TIMELINE AND COMPENSATION 2019SAE REPORTING TIMELINE AND COMPENSATION 2019
SAE REPORTING TIMELINE AND COMPENSATION 2019Shweta Lal
 
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]Vikas Dhiman
 
Validation utility system
Validation utility systemValidation utility system
Validation utility systemArpitSuralkar
 
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...Dr Raghu Khimani
 
3 TOPIC3 Forensic Laboratory Techniques SUN.pptx
3 TOPIC3 Forensic Laboratory Techniques SUN.pptx3 TOPIC3 Forensic Laboratory Techniques SUN.pptx
3 TOPIC3 Forensic Laboratory Techniques SUN.pptxzenAlkaff
 
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSjyothibhat21
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES anubhavdubey18
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingPaulyne Wairimu
 
Hair drug analysis ppt
Hair drug analysis pptHair drug analysis ppt
Hair drug analysis pptajaysharma1358
 

Mais procurados (20)

good laboratory practices
 good laboratory practices good laboratory practices
good laboratory practices
 
Exploratory drug research
Exploratory drug researchExploratory drug research
Exploratory drug research
 
Extractable and leachables
Extractable and leachablesExtractable and leachables
Extractable and leachables
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
GLP
GLPGLP
GLP
 
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...Use of Chemical Characterization to Assess the Equivalency of Medical Devices...
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...
 
Good Laboratory Practices.pptx
Good Laboratory Practices.pptxGood Laboratory Practices.pptx
Good Laboratory Practices.pptx
 
Drug Testing in the Workplace – Fit for Purpose
Drug Testing in the Workplace – Fit for PurposeDrug Testing in the Workplace – Fit for Purpose
Drug Testing in the Workplace – Fit for Purpose
 
Medical Technologist powerpoint
Medical Technologist powerpointMedical Technologist powerpoint
Medical Technologist powerpoint
 
Analysis of raw materials
Analysis of raw materialsAnalysis of raw materials
Analysis of raw materials
 
SAE REPORTING TIMELINE AND COMPENSATION 2019
SAE REPORTING TIMELINE AND COMPENSATION 2019SAE REPORTING TIMELINE AND COMPENSATION 2019
SAE REPORTING TIMELINE AND COMPENSATION 2019
 
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]
Tabular summary of New Drugs & Clinical Trials Rules, 2019 [INDIA]
 
Schedule y
Schedule ySchedule y
Schedule y
 
Validation utility system
Validation utility systemValidation utility system
Validation utility system
 
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...
Introduction to Toxicology and Forensic Toxilogical Examination and it's sign...
 
3 TOPIC3 Forensic Laboratory Techniques SUN.pptx
3 TOPIC3 Forensic Laboratory Techniques SUN.pptx3 TOPIC3 Forensic Laboratory Techniques SUN.pptx
3 TOPIC3 Forensic Laboratory Techniques SUN.pptx
 
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and grouping
 
Hair drug analysis ppt
Hair drug analysis pptHair drug analysis ppt
Hair drug analysis ppt
 

Semelhante a Drug testing in the workplace

Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agenciesUrmila Aswar
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentMANIKANDAN V
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterOPUNITE
 
DEBRA R. COMER CrossroadsA Case Against Workplace Drug Tes
DEBRA R. COMER CrossroadsA Case Against Workplace Drug TesDEBRA R. COMER CrossroadsA Case Against Workplace Drug Tes
DEBRA R. COMER CrossroadsA Case Against Workplace Drug TesLinaCovington707
 
Rx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyRx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyOPUNITE
 
Work-Place Alcohol and Other Drug Testing by UA
Work-Place Alcohol and Other Drug Testing by UAWork-Place Alcohol and Other Drug Testing by UA
Work-Place Alcohol and Other Drug Testing by UAAtlantic Training, LLC.
 
Veena Sanjay Katoriya
Veena Sanjay KatoriyaVeena Sanjay Katoriya
Veena Sanjay KatoriyaVEENA18
 
Clinical trials I II III
Clinical trials I II IIIClinical trials I II III
Clinical trials I II IIInandhujaan
 
WP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandWP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandAlok Anand
 
4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdfASSAM DOWN TOWN UNIVERSITY
 
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.PakistanPharmaCareerDoor
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentSujith Thokala
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerOPUNITE
 
Unit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesUnit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesAshok Kumar
 
Medical & Healthcare Products Regulatory Agency (MHRA)
Medical & Healthcare Products Regulatory Agency (MHRA)Medical & Healthcare Products Regulatory Agency (MHRA)
Medical & Healthcare Products Regulatory Agency (MHRA)PriyalBagwe
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?Julian Buchanan
 

Semelhante a Drug testing in the workplace (20)

Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
 
Drug Testing Index
Drug Testing IndexDrug Testing Index
Drug Testing Index
 
Chapter 3
Chapter 3Chapter 3
Chapter 3
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and Development
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeter
 
Sample of writing
Sample of writingSample of writing
Sample of writing
 
DEBRA R. COMER CrossroadsA Case Against Workplace Drug Tes
DEBRA R. COMER CrossroadsA Case Against Workplace Drug TesDEBRA R. COMER CrossroadsA Case Against Workplace Drug Tes
DEBRA R. COMER CrossroadsA Case Against Workplace Drug Tes
 
Rx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthyRx15 le wed_1115_1_meinhofer_2simon-worthy
Rx15 le wed_1115_1_meinhofer_2simon-worthy
 
Work-Place Alcohol and Other Drug Testing by UA
Work-Place Alcohol and Other Drug Testing by UAWork-Place Alcohol and Other Drug Testing by UA
Work-Place Alcohol and Other Drug Testing by UA
 
Veena Sanjay Katoriya
Veena Sanjay KatoriyaVeena Sanjay Katoriya
Veena Sanjay Katoriya
 
Clinical trials I II III
Clinical trials I II IIIClinical trials I II III
Clinical trials I II III
 
WP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok AnandWP_Life Sciences_Drug Utilization_Alok Anand
WP_Life Sciences_Drug Utilization_Alok Anand
 
4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf
 
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinner
 
Unit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesUnit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelines
 
Medical & Healthcare Products Regulatory Agency (MHRA)
Medical & Healthcare Products Regulatory Agency (MHRA)Medical & Healthcare Products Regulatory Agency (MHRA)
Medical & Healthcare Products Regulatory Agency (MHRA)
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?
 

Último

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...anjaliyadav012327
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxShobhayan Kirtania
 

Último (20)

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptx
 

Drug testing in the workplace

  • 1. Drug Testing in the Workplace Judith Soto – Group Leader, Mitchell Bragg, Reyes Gutierrez, & Brandon Edwards PSY 103 Summer 2013
  • 2. Introduction Substance abuse has made it necessary for many American firms to create strategies that would help keep it out of the workplace. Employment drug testing is a powerful risk tool that provides far-reaching organizational benefits. Some firms have sponsored extravagant programs to control alcohol and drug abuse. However, these programs have tended to rely on a supervisor's, a coworker's, or an employee's judgment about the presence of substance abuse in another individual or themselves. In the 1980s, some firms began to adopt drug and alcohol testing as an fair strategy to detect and control substance abuse. Supporters of this approach claim that an employee's positive test results can be linked to impairments in job performance, safety risks, and absenteeism. The drug testing industry was born 30 years ago, after the launch of federal drug testing requirements in the 1980s.
  • 3. What is the Definition of drugs? • Any substance that when taken into the living organism may modify one or more of its functions. • This definition includes aspirin, milk of magnesia, penicillin, caffeine, alcohol, marijuana, and cocaine.
  • 4. Drug Testing Trends • There has been a growing trend of drug testing from the mid- 1980’s to the present. • One study shows that 18% of Fortune 500 companies tested employees in 1985, and 1991 the proportion double to more than 40%.
  • 5. Drug Testing Trends Cont. • A survey in 1988 indicated increases in the testing of both applicants and current employees for drugs. • 38% of organizations tested job applicants, to 28% in 1987. • 36% tested current employees, to 28% 1986.
  • 6. Drug Testing Trends Cont. • By 1991, 48% of Fortune 1000 firms engaged in some type of drug testing. • Recent studies have shown about 42% get pre-employment tested. • About 29% already employed get tested.
  • 7. Drug Testing Pros • Pre-employment testing can identify users and prevent cost of recruitment and training. • Random-testing can help raise awareness and deter illegal drug use.
  • 8. Drug Testing Pros Cont. • Testing can prevent accidents • It can reduce compensation cost • Prevent abusers from taking away from the company’s competitive edge. • Testing programs have been shown to improve employee morale and productivity
  • 9. Drug Testing Pros Cont. • Testing can reduce absenteeism. • Reduce turnover and theft rates. • Vacant positions, as they become available, will attract mature, responsible, drug-free applicants.
  • 10. Drug Testing Pros Cont. • Drug addicts will soon be eliminated from the workplace. • Improved efficiency and heightened public confidence in the product and/or services of the company may cover and even exceed the cost of testing.
  • 11. Drug Testing Cons Cont. • Management won't win any workplace popularity contests. • Management may be accused of invading employees' privacy. A written agreement of compliance with the drug-testing policy must be signed by each employee prior to its implementation. Signing the same agreement will be a condition of employment for future recruits to the organization.
  • 12. Drug Testing Cons Cont. • Management may wish to offer a signing bonus to help retain reliable, long- term employees. • Testing equipment and personnel may be expensive. However, bulk rates are often available for large companies.
  • 13. Drug Testing Cons Cont. • Although drug testing detects recent drug use, it does not show if an employee is presently impaired and unable to perform job functions. • Drug users work only two thirds as efficiently ad nonusers • Companies pay up to 300 percent more for medical cost for drug users that for nonusers.
  • 14. Drug Testing Cons Cont. • The cost of worker’s compensation claims tend to be about five times higher for users than nonusers.
  • 15. Facts: • In 1997, two states – Arizona and California – adopted laws that permit the use of marijuana for certain specific medical purposes. • Americans concerned about the “drug problem” has two parts: o One involves the misuse of legal and potentially helpful drugs such as codeine and morphine. o Two involves illegal drugs with no medical value such as LSD and heroin.
  • 16. More Facts: • Research indicates that 74 percent of illicit drug users are employed in full-time positions. • One out of four hospital admissions is from drug use. • Forty percent of all accidents that result in hospitalization are because of drugs.
  • 17. More Facts: • The national cost of all accidents from drug abuse is $41 billion per year. • The Drug-Free Act of 1988 requires Federal grantees and contractors having a contract for property or services of $25,000 or more to provide a drug free workplace.
  • 18. More Facts: • While marijuana is still the number one most-abused drug globally, prescription drugs have moved into second place, overshadowing cocaine. Technology has played a big role in these changes. For example, the street distributor has morphed into the Internet distributor, making it easier than ever to access prescription medication without ever visiting a doctor. • The use of pill mills, which are clinics, doctors, or pharmacies that are prescribing large amounts of prescription medication for non- medical use, is also becoming prominent in the United States, prompting abusers to travel across state lines to access these mills • Drug Identification Kits: Law enforcement and school officials now have the ability to instantly test substances found while out in the field or on school premises. It is a very cost-effective method of substance testing, and eliminates the need for lab analysis which can cost up to $200-300.
  • 19. What Can Be Tested? • Metabolites and Metabolism • Urine • Drug Urinalysis • Breath • Saliva • Blood • Hair • Sweat
  • 20. Testing Methods Confirmatory Tests • Immunoassays • Enzyme Immunoassays • Radioimmunoassay • Gas Chromatography • Mass Spectrometry • Thin-Layer Chromatography
  • 21. What to Avoid Before A Drug Test • Alka-Seltzer Plus • Allerest • Bronkaid • Contac • Donnagel • Nyquil • Primatene • Sinutab • Sudafed • Triaminic • Poppy seeds
  • 24. Drug Testing by Industry
  • 25. Conclusion • There are many pros and cons to drug testing but there is one thing that no one can dispute and that is the fact that drugs do impair a person as long as the drugs are in their system. • Consequences of drug use are NOT restricted to a minority of heavy users or “addicts” who are easily identified. • Often problems can arise from occasional use/intoxication. • Most workplaces are concerned about the impact alcohol and other drugs may have in their workplace. • Most workplaces have at least one response in place to address alcohol and other drug related harm. • Most workplaces are not considering doing anything further to address alcohol and other drug issues.
  • 26. Works Consulted • Beverly A. Potter, Ph.D. and J. Sebastian Orfali, M.A. Pass The Test An Employee Guide To Drug Testing. Berkeley: Ronin Publishing, Inc, 1999. • Breugem, Lindsay. SafeWork. 2006. 26 June 2013 <http://www.safework.sa.gov.au/uploaded_files/workplace_report.pdf>. • Colakis, Peter N., and Roger Bruce. "Drug Testing In The Workplace." Professional Safety 52.7 (2007): 31-36. Academic Search Premier. Web. 24 June 2013. • DiThomas, Melissa. Occupational Health & Safety. 1 October 2012. 26 June 2013 <http://ohsonline.com/Articles/2012/10/01/Drug-Testing-Promotes-Workplace- Safety.aspx?m=1>. • Employment Background Solutions. 2010. 26 June 2013 <http://www.ebiinc.com/drug- testing-facts.html>. • Get The Facts. 1998-2013. 26 June 2013 <http://www.drugwarfacts.org/cms/Drug_Testing_Employee#sthash.uhZ4VfQE.Q2vPSI93.d pbs. • Hartwell, Tyler D.Steele, Paul D. "Prevalence Of Drug Testing In The Workplace." Monthly Labor Review 119.11 (1996): 35. MasterFILE Premier. Web. 24 June 2013.
  • 27. Works Consulted Cont.• Gray, James. Tikkun. 25 June 2013. 26 June 2013 <http://www.tikkun.org/nextgen/drug- prohibition-is-the-problem-reflections-from-a-former-judge>. • Monroe, Judy. The Facts About Drug Testing. New York: Macmillan Publishing Company, 1990. • Newton, David E. Drug Testing An Issue for School, Sports, and Work. Berkely Heights: Enslow Publishers, 1999. • Office of Justice Programs. n.d. 26 June 2013 <http://www.bjs.gov/content/dcf/du.cfm >. • Steeves, Richard. "Recognising Drug Abuse At Work." Occupational Health 63.9 (2011): 27- 30. Academic Search Premier. Web. 24 June 2013. • West, Robert H. Coombs and Louis Jolyon. Drug Testing Issues & Options. New York: Oxford Universtity Press, 19991. • Wikipedia The Free Encyclopedia. 26 June 2013. 26 June 2013 <https://en.wikipedia.org/wiki/Psychoactive_drug>. • Zeidner, Rita. "PUTTING DRUG SCREENING TO THE TEST. (Cover Story)." HR Magazine 55.11 (2010): 25. MasterFILE Premier. Web. 24 June 2013. • 2013. 26 June 2013 <http://www.testcountry.com/categories.html?cat=256&left>.